Drug
Bezisterim clinical trials
Also written NE3107, HE3286 and Triolex.
- studies test it
- 11
- open now
- 0
- in phase 3
- 1
- first study started
- 2007
How studies write it
Studies that test it under each name
Studies by the year they started
11 studies that test it; most in 2008 (3)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 5
- Phase 2
- 8
- Phase 3
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 9 · Other 2
Harbor Therapeutics (5) · BioVie Inc. (4) · Neurological Associates of West Los Angeles (2)
Studies
Open first, then newest update. How each study uses bezisterim is read from its arms, and is right about nine times in ten.
Testing it · 11
- NE3107 in Adults With Neurological Symptoms of Long COVIDCompletedPhase 2BioVie Inc.NCT06847191Written as NE3107
- A Study of NE3107 in Early Parkinson'sCompletedPhase 2BioVie Inc.NCT06757010Written as NE3107
- Insulin-sensitizing NE3107 in Improving Sleep and Fatigue in Subjects With Traumatic Brain InjuryTerminatedPhase 2Neurological Associates of West Los AngelesNCT05970575Written as NE3107
- Insulin-Sensitizing Anti-Inflammatory Small Molecule for Investigative Treatment of DementiaCompletedPhase 2Neurological Associates of West Los AngelesNCT05227820Written as NE3107
- A Phase 3 Study of NE3107 in Probable Alzheimer's DiseaseCompletedPhase 3BioVie Inc.NCT04669028Written as NE3107
- NE3107 Activity and Safety in Patients With Parkinson's Disease Using LevodopaCompletedPhase 1/2BioVie Inc.NCT05083260Written as NE3107
- Safety, Tolerance and Activity of HE3286 in Patients With Type 2 Diabetes MellitusCompletedPhase 2Harbor TherapeuticsNCT00694057Written as HE3286
- Safety, Tolerance, Pharmacokinetics and Activity of HE3286 in Patients With Rheumatoid ArthritisCompletedPhase 1/2Harbor TherapeuticsNCT00712114Written as HE3286
- Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative ColitisCompletedPhase 1/2Harbor TherapeuticsNCT00628433Written as HE3286
- A Study of the Safety, Tolerance and Assessment of HE3286 on Insulin Sensitivity and Hepatic Glucose ProductionCompletedPhase 1Harbor TherapeuticsNCT00991107Written as HE3286
- Safety, Pharmacokinetics and Potential Activity of HE3286 in Obese Adult SubjectsCompletedPhase 1Harbor TherapeuticsNCT00555451Written as HE3286
Codes
What other systems call bezisterim · ClinicalTrials.gg INT005192
- UNII (FDA) PH8858757IBEZISTERIMConfirmed FDA, Wikidata
- Wikidata Q27286562bezisterimConfirmed FDA, Wikidata
- NCI Thesaurus C203210BezisterimOne source FDA
- DrugBank DB05212One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | PH8858757I | BEZISTERIM | Confirmed FDA, Wikidata |
| Wikidata | Q27286562 | bezisterim | Confirmed FDA, Wikidata |
| NCI Thesaurus | C203210 | Bezisterim | One source FDA |
| DrugBank | DB05212 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.